Blog

FDA approves device based on Vanderbilt invention to ID parathyroid during head and neck surgeries

Ten years after Professor of Biomedical Engineering Anita Mahadevan-Jansen discovered that parathyroid tissues glow under near-infrared light, the FDA has approved a device based on the technology for surgical use.


Ethnicity proves reliable indicator of what microbes thrive in the gut

Research increasingly links the gut microbiome to a range of human maladies, including inflammatory bowel disease, diabetes and even cancer.


NEI grants help bolster glaucoma research efforts

Two Vanderbilt Eye Institute (VEI) researchers were recently awarded National Eye Institute (NEI) Audacious Goals Initiative (AGI) for Regenerative Medicine grants for $6.8 million over five years to develop new treatments for optic neuropathies and glaucoma, the leading cause of irreversible blindness.


Analyzing single-cell landscapes

Single-cell RNA sequencing is a powerful tool for studying cellular diversity, for example in cancer where varied tumor cell types determine diagnosis, prognosis and response to therapy.


Team spots clue to rare lung and kidney diseases

Pulmonary-renal syndrome (PRS) refers to a group of rare but potentially fatal conditions that nearly always are caused by a misguided attack by the body’s immune system on the lungs and kidneys. Coughing up blood and blood in the urine are telltale signs.


Faculty invited to submit Discovery Grant and Research Scholar Grant proposals

The Office of the Provost invites faculty to submit proposals for the next round of Discovery Grants and Research Scholar Grants.

Both awards are open to all full-time VU-employed (provost-reporting) faculty. Proposals that advance research in areas related to race, diversity and inclusivity are encouraged.